Where do Mirum Pharmaceuticals, Inc.'s ratios come from?

Every ratio is computed from Mirum Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Operating margin	-139.8%-136pp	-4.2%+4.6pp	-8.9%+4.4pp	-13.3%+6.8pp	-20.1%+5.9pp
Net margin	-140.2%-136pp	-4.5%+4.3pp	-8.8%+4.9pp	-13.6%+6.7pp	-20.4%+5.7pp
EBITDA margin	-135.4%-136pp	0.4%+4.1pp	-3.7%+3.9pp	-7.7%+6.1pp	-13.8%+5.2pp
Free cash flow margin	-30.3%-40.8pp	10.5%—	——	——	——
Returns
Return on equity	-335.8%-327pp	-8.6%+7.2pp	-15.8%+8.4pp	-24.2%+8.9pp	-33.1%+4.0pp
Return on assets	-101%-98.0pp	-3.1%+2.6pp	-5.7%+2.7pp	-8.4%+3.1pp	-11.5%+1.8pp
Efficiency
Asset turnover	0.7×0.0×	0.7×0.0×	0.6×0.0×	0.6×+0.1×	0.6×+0.1×
Liquidity
Current ratio	2.1×-0.6×	2.7×-0.6×	3.3×+0.2×	3.1×-0.1×	3.2×+0.1×
Quick ratio	2×-0.6×	2.6×-0.6×	3.2×+0.2×	3×-0.1×	3×+0.1×
Cash ratio	1×-0.3×	1.2×-0.2×	1.4×+0.1×	1.3×-0.1×	1.4×-0.2×
Leverage
Debt-to-equity	0.1×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Interest coverage	-55.3×-53.7×	-1.5×+1.4×	-2.9×+1.1×	-4×+1.3×	-5.3×+0.8×
Per Share
Book value per share	$4.12-34.3%	$6.27+22.3%	$5.12-0.1%	$5.13+7.5%	$4.77+0.5%
Valuation
Market capitalization	$5.57B+36.5%	$4.08B+10.8%	$3.68B+45.5%	$2.53B+14.7%	$2.21B+11.2%
Enterprise value	$5.33B+38.8%	$3.84B+10.8%	$3.46B+47.1%	$2.35B+15.7%	$2.03B+13.5%
Price / sales	9.8×+2.0×	7.8×0.0×	7.8×+1.9×	5.9×+0.1×	5.8×-0.1×
Price / book	23×+10.0×	13×+0.4×	12.6×+2.7×	9.9×+0.5×	9.5×+0.7×
EV / sales	9.4×+2.0×	7.4×0.0×	7.3×+1.9×	5.5×+0.1×	5.4×0.0×
Free cash flow yield	-3.1%-4.4pp	1.3%—	——	——	——
Earnings yield	-14.3%-13.8pp	-0.6%+0.6pp	-1.1%+1.2pp	-2.3%+1.2pp	-3.5%+0.9pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Mirum Pharmaceuticals, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Mirum Pharmaceuticals, Inc.'s ratios come from?: Every ratio is computed from Mirum Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.